Biochemical parameters and anthropometry predict NAFLD in obese children

Claudio Maffeis1, Claudia Banzato, Francesca Rigotti

  • 1Unit of Pediatric Diabetes, Clinical Nutrition and Obesity, Department of Life and Reproduction Sciences, University of Verona, Verona, Italy.

Insights

This study developed a predictive model for nonalcoholic fatty liver disease (NAFLD) in obese children using simple measurements. The model accurately identifies children at high risk for NAFLD, aiding early intervention.

Area of Science:

  • Pediatrics
  • Hepatology
  • Metabolic Disorders

Background:

  • Nonalcoholic fatty liver disease (NAFLD) is a growing concern in obese children.
  • Early identification of NAFLD in pediatric populations is crucial for timely intervention and management.
  • Obesity is a significant risk factor for the development of NAFLD.

Purpose of the Study:

  • To develop and validate a predictive model for nonalcoholic fatty liver disease (NAFLD) in obese children.
  • To identify key clinical and biochemical markers associated with NAFLD risk in this population.
  • To provide a tool for physicians to identify high-risk children for NAFLD.

Main Methods:

  • A cohort of 56 obese 10-year-old children was recruited.
  • Biochemical blood tests were performed to assess metabolic markers.
  • Magnetic resonance imaging (MRI) was used for definitive NAFLD diagnosis.
  • A predictive model was constructed using variables including waist-to-height ratio, homeostasis model assessment of insulin resistance (HOMA-IR), adiponectin, and alanine aminotransferase (ALT).

Main Results:

  • The combined model including waist-to-height ratio, HOMA-IR, adiponectin, and ALT demonstrated high accuracy in predicting NAFLD (AUROC = 0.94).
  • Even without adiponectin, the model retained good predictive accuracy (AUROC = 0.88).
  • The predictive model effectively differentiated between children with and without NAFLD.

Conclusions:

  • A predictive equation utilizing routinely available variables can accurately identify obese children at high risk for NAFLD.
  • This model can assist clinicians in risk stratification and targeted screening for pediatric NAFLD.
  • Early detection through predictive modeling can facilitate timely management strategies for NAFLD in obese children.

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...